Literature DB >> 31180331

Interictal epileptiform discharges in sleep and the role of the thalamus in Encephalopathy related to Status Epilepticus during slow Sleep.

Steve A Gibbs1, Lino Nobili2, Péter Halász3.   

Abstract

EEG activation of interictal epileptiform discharges (IEDs) during NREM sleep is a well-described phenomenon that occurs in the majority of epileptic syndromes. In drug-resistant focal epilepsy, IED activation seems to be related to slow wave activity (SWA), especially during arousal fluctuations, namely phase A of the cyclic alternating pattern (CAP). Conversely, in childhood focal epileptic syndromes, including Encephalopathy related to Status Epilepticus during slow Sleep (ESES), IED activation seems primarily modulated by sleep-inducing and maintaining mechanisms as reflected by the dynamics of spindle frequency activity (SFA) rather than SWA. In this article, we will review the effect of sleep on IEDs with a particular attention on the activation and modulation of IEDs in ESES. Finally, we will discuss the role of the thalamus and cortico-thalamic circuitry in this syndrome.

Entities:  

Keywords:  EEG; continuous spike-and-wave discharges during sleep; encephalopathy related to status epilepticus during slow sleep; sleep; thalamocortical system

Mesh:

Year:  2019        PMID: 31180331     DOI: 10.1684/epd.2019.1058

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  2 in total

Review 1.  Electrical Status Epilepticus During Slow-wave Sleep (ESES): Current Perspectives.

Authors:  Pinar Arican; Pinar Gencpinar; Nihal Olgac Dundar; Hasan Tekgul
Journal:  J Pediatr Neurosci       Date:  2021-07-02

Review 2.  Sleep and epilepsy: A snapshot of knowledge and future research lines.

Authors:  Lino Nobili; Birgit Frauscher; Sofia Eriksson; Steve Alex Gibbs; Peter Halasz; Isabelle Lambert; Raffaele Manni; Laure Peter-Derex; Paola Proserpio; Federica Provini; Al de Weerd; Liborio Parrino
Journal:  J Sleep Res       Date:  2022-04-29       Impact factor: 5.296

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.